The basic principles of the molecular mechanism leading to regulated insulin release in pancreatic B-cells have been shown to be similar to that leading to neurotransmitter release in neurons (1-5). Several lines of evidence have shown that SNAP-25 1 (6) plays an important role in the complex mechanism leading to regulated exocytosis in both neurons and endocrine cells. SNAP-25 has thus been shown to be associated with the plasma membrane and to serve as a receptor for the general cytosolic fusion proteins SNAP and NSF. It is therefore called a tSNARE (target membrane SNAP receptor) (7, 8) . It has been shown to bind to syntaxin, another tSNARE, and to the vesicle membrane SNAP receptors (vSNAREs), VAMP, and synaptotagmin (9 -11). Antibodies against SNAP-25 and a peptide corresponding to the carboxyl-terminal part of SNAP-25 have been shown to inhibit exocytosis when introduced into permeabilized cells (12). Finally, the botulinum neurotoxins A and E hydrolyze SNAP-25, and this is accompanied by an inhibition of exocytosis in neurons (13-17) and endocrine cells (1, 3).
The basic principles of the molecular mechanism leading to regulated insulin release in pancreatic B-cells have been shown to be similar to that leading to neurotransmitter release in neurons (1) (2) (3) (4) (5) . Several lines of evidence have shown that SNAP-25 1 (6) plays an important role in the complex mechanism leading to regulated exocytosis in both neurons and endocrine cells. SNAP-25 has thus been shown to be associated with the plasma membrane and to serve as a receptor for the general cytosolic fusion proteins SNAP and NSF. It is therefore called a tSNARE (target membrane SNAP receptor) (7, 8) . It has been shown to bind to syntaxin, another tSNARE, and to the vesicle membrane SNAP receptors (vSNAREs), VAMP, and synaptotagmin (9 -11) . Antibodies against SNAP-25 and a peptide corresponding to the carboxyl-terminal part of SNAP-25 have been shown to inhibit exocytosis when introduced into permeabilized cells (12) . Finally, the botulinum neurotoxins A and E hydrolyze SNAP-25, and this is accompanied by an inhibition of exocytosis in neurons (13) (14) (15) (16) (17) and endocrine cells (1, 3) .
Several studies in yeast and in eukaryotic cells have shown that the basic principles of docking and fusion of all transport vesicles within a cell and in different cell types are similar (18, 19) . The above mentioned SNARE proteins involved in the final step of the regulated secretory pathway in neurons and endocrine cells are not or only weakly expressed in other cell types, but some ubiquitously expressed isoforms of the neuronal counterparts have been identified in non-neuronal cells. Cellubrevin has been shown to be a ubiquitously expressed isoform of VAMP (20) . Several isoforms of syntaxin have also been described (21) . Whereas syntaxin-1 is expressed predominantly in neurons and neuroendocrine cells, syntaxin-2, -3, -4, and-5 are expressed in many tissues (21) . More recently SNAP-23, a ubiquitously expressed isoform of SNAP-25, was cloned from human cells and shown to be 59% identical and 72% similar to SNAP-25 at the amino acid level (22) . Two isoforms, SNAP-23A and B, have been described in human neutrophils and HL-60 cells, with SNAP-23B lacking 53 amino acids in the middle of the molecule (23) . Syndet, another SNAP-25 family member, has been cloned from mouse 3T3-L1 cells and is 86% identical to the human SNAP-23 protein (24) . In vitro, it has been shown that SNAP-23 shows similar binding characteristics to SNAP-25 in that it binds to different syntaxin isoforms, with strongest affinity to syntaxin-1 and -4 (22, 25) . Together with VAMP-1 or -2, it binds strongly to the cytosolic protein SNAP (22) . In addition, in analogy to SNAP-25, binding to syntaxin 4 was inhibited by Munc-18 (25) . The functional role of SNAP-23 in vivo, however, remains to be elucidated. Here we show that SNAP-23 can replace SNAP-25 in the process of insulin secretion when it is overexpressed.
EXPERIMENTAL PROCEDURES
Materials-The cDNA coding for SNAP-25a (26) tated to Ala) fused to the Escherichia coli maltose-binding protein was used for cell permeabilization and is referred to below as SLO (27) . The monoclonal anti-SNAP-25 antibody was purchased from Sternberger Monoclonals Incorporated, Baltimore, MD, and the polyclonal antibody against actin is a generous gift from Dr. Gabbiani, Geneva, Switzerland. The polyclonal antibody against SNAP-23 was produced against a synthetic peptide corresponding to the 12 carboxyl-terminal amino acids of SNAP-23 (28) .
In BoNT/E at a final concentration of 50 nM for various time periods at 37°C. Samples were then boiled in SDS-sample buffer and subjected to SDS-PAGE.
Cell Culture and Transfection-HIT-T15 cells (29, 30) were cultured in RPMI 1640, 10% fetal calf serum, 2.05 mM glutamine, 32.5 M glutathione, 0.1 M seleneous acid. For transient transfections, HIT cells were seeded in 24-well plates at a density of 3.5 ϫ 10 5 cells/well. After 2 days in culture, cells were co-transfected using the lipopolyamine Transfectam (Promega) with 2.5 g of the vector encoding human proinsulin and 2.5 g of empty vector or vector containing cDNAs for either SNAP-23 or SNAP-25. When transfected cells were to be sorted, co-transfection was performed using 2.5 g of vector containing cDNA for CD4 and 2.5 g of vector with SNAP-23 cDNA.
Sorting of CD4 Expressing Cells-Two days after co-transfection of CD4 and SNAP-23 cells were trypsinized. The cell suspension (2 ϫ 10 7 cells in 18 ml of complete medium) was incubated with an anti-CD4 monoclonal antibody coupled to magnetic beads (1.3 ϫ 10 7 beads, Dynal, Oslo, Norway) for 1 h at 4°C with gentle agitation. Transfected cells were then separated from untransfected cells using a magnetic tube holder. Positive cells attached to the magnetic beads were washed twice with medium and plated at a density of 1.5 ϫ 10 5 cells/well into 96-well plates coated with bovine corneal endothelial cell matrix (Novamed Ltd., Jerusalem, Israel). Culture was continued for 1 day before cells were used for a secretion assay and finally lysed in SDS-sample buffer for SDS-PAGE. For immunofluorescence, cells were plated on poly-L-lysine coated coverslips.
Immunofluorescence-One day after sorting, cells were fixed for 10 min at room temperature in PBS, 4% paraformaldehyde, permeabilized in acetone for 30 s at room temperature, and blocked for 15 min in DPBS, 5% bovine serum albumin before incubation with the polyclonal antibody against SNAP-23 (diluted 1:200) for 1 h in DPBS, 1% bovine serum albumin. Cells were washed twice in DPBS, incubated with a fluorescein isothiocyanate-labeled secondary antibody (1:80, Sigma), washed, and then visualized with an Axiophot fluorescence microscope.
Secretion ) for a secretion period of 7 min at 37°C. Secretion from unsorted transfected cells was estimated by measuring the amount of human C-peptide released into the medium using an enzyme-linked immunosorbent assay (ELISA; Dako, Cambridge, UK). This ELISA does not cross-react with the endogenous hamster C-peptide of the HIT cells. Secretion of CD4-positive sorted cells was measured by radioimmunoassay using human insulin standard (which dilutes in a linear fashion versus the endogenous hamster insulin secreted by HIT cells) and anti-insulin serum from Novo-Nordisk, Bagsvaerd, Denmark (31) .
SDS-PAGE and Western Blot-SDS-gel electrophoresis was performed using 10% polyacrylamide gels according to Laemmli et al. (32) . Transfer of proteins to nitrocellulose was performed as described (33) . The nitrocellulose membranes were then blocked for 1 h at room temperature in TBS (25 mM Tris, 150 mM NaCl, pH 7.4), 5% dry milk before incubation with the first antibody in TBS, 5% dry milk, 0.1% Tween-20 overnight at 4°C. The primary antibody was then visualized using a horseradish peroxidase-coupled secondary antibody combined with the enhanced chemiluminescence detection procedure from Amersham International (Amersham, Buckinghamshire, UK).
RESULTS

SNAP-23 Is Resistant to Cleavage by BoNT/E-It has been
shown that SNAP-23 is resistant to cleavage by BoNT/A (34), but so far it is not known whether SNAP-23 is also resistant to cleavage by BoNT/E. SNAP-25 is hydrolyzed by BoNT/E between the residues Arg 180 -Ile 181 (13, 35) . These two residues are conserved in SNAP-23, but the adjacent residues are different (22) . In addition, the SNARE motifs (36) , which have been shown to be essential for binding of all botulinum and tetanus neurotoxins to their respective substrates, are not completely conserved in SNAP-23. We therefore examined whether SNAP-23 can be hydrolyzed by BoNT/E. SNAP-25 and SNAP-23 were in vitro translated in the presence of [ (a byproduct of proinsulin conversion) and not C-peptide from the endogenous hamster proinsulin of the HIT cells. SNAP-23 or mock transfected cells (control) were permeabilized with SLO and treated with BoNT/E before insulin release was induced by raising the free Ca 2ϩ concentration from 0.1 M (basal) to 10 M (stimulated). When control cells were treated with BoNT/E, Ca 2ϩ -induced insulin release was inhibited by about 50%. Insulin release was almost completely restored, however, when cells were transfected with SNAP-23 but not when they were transfected with SNAP-25 (Fig. 2) .
While our data show that overexpressed SNAP-23 reconstitutes insulin secretion in BoNT/E-treated HIT cells, they raise the question as to whether insulin release is restored because SNAP-23 replaces SNAP-25 or because the presence of SNAP-23 competitively inhibits cleavage of SNAP-25 by BoNT/E. To distinguish between these two possibilities, we performed co-transfection experiments with CD4 and SNAP-23, which allowed us to sort transfected from untransfected cells using an anti-CD4 antibody coupled to magnetic beads. As shown in Fig. 3 , this approach yields a population of cells of which about 80% are strongly positive for SNAP-23 by immunofluorescence. Note, however, that the level of expression of SNAP-23 is very heterogeneous. Such positive sorted cells were permeabilized with SLO, treated with BoNT/E, and incubated in a high Ca 2ϩ -containing buffer to induce insulin release. Under these conditions, approximately 65% of the secretory response (cells without toxin) was reconstituted by overexpression of SNAP-23 in the transfected cells (not shown). The less efficient reconstitution in this series of experiments compared with that seen from the cells co-transfected with SNAP-23 and human insulin (Fig. 2 ) is taken to reflect the different experimental approaches. Thus, the population of sorted CD4-positive cells, although greatly enriched in SNAP-23-positive cells compared with the unsorted population, was still contaminated with some cells not expressing SNAP-23. Furthermore, reconstitution may not be as efficient in those cells expressing only low levels of SNAP-23. By contrast, when measuring human C-peptide secretion from cells co-transfected with SNAP-23 and human insulin, it is expected that cells with high levels of SNAP-23 expression will also express high levels of human insulin and will, as such, dominate in this assay.
After the secretion period, cells were lysed in SDS-sample buffer for gel electrophoresis. Total cellular proteins were Western blotted using a polyclonal antibody against the carboxyl terminus of SNAP-23 (Fig. 4, upper panel) , a monoclonal antibody against SNAP-25 (Fig. 4, middle panel) or a polyclonal antibody against actin (Fig. 4, lower panel) . Note that HIT cells express SNAP-23 endogenously (Fig. 4, upper panel, lanes 4 -6) although this could not be detected by immunofluorescence, and SNAP-23-transfected HIT cells strongly overexpress the protein (Fig. 4, upper panel, lanes 1-3) . In agreement with the in vitro results, SNAP-25 was hydrolyzed by BoNT/E, whereas SNAP-23 was resistant. Most significantly, the presence of large amounts of SNAP-23 did not influence the cleavage of SNAP-25 by BoNT/E. 
SNAP-23 Reconstitutes Insulin Secretion
Taken together, these data demonstrate that SNAP-23 is resistant to cleavage by BoNT/E in vivo as well as in vitro and that, when overexpressed, it can substitute for SNAP-25 in the process of insulin secretion in BoNT/E treated HIT cells. DISCUSSION SNAP-23 is expressed predominantly in non-neuronal, nonendocrine cells (28) . Some of these cell types do possess a regulated transport pathway, with one example being those which incorporate the Glut4 glucose transporter into the plasma membrane in response to insulin (38, 39) . Others, like fibroblasts, do not appear to have a conventional regulated exocytotic pathway but do display Ca 2ϩ -regulated fusion events (40, 41) . Two questions arise from this. First, what is the true physiological role of SNAP-23? The close similarity between SNAP-23 and SNAP-25 suggests that it may also be involved in the fusion mechanism of transport vesicles with the plasma membrane. Second, how different is a regulated exocytotic event in neuronal/endocrine cells versus non-neuronal cells? Here we show that SNAP-23 can replace SNAP-25 in the process of insulin release. These results strengthen the hypothesis that SNAP-23 in non-neuronal cells may also be involved in exocytosis. They also provide further evidence that the mechanism of regulated exocytosis in neuronal and non-neuronal cells is similar.
In the present study, we have obtained direct evidence that SNAP-23 can function in regulated exocytosis. This was made possible following the observation that SNAP-23, in contrast to SNAP-25, is not hydrolyzed by BoNT/E. This allows one to study the impact of overexpression of SNAP-23 on insulin release from cells in which SNAP-25 has been inactivated by BoNT/E. It was important for such a study to demonstrate in parallel that overexpression of SNAP-23 did not abolish toxin cleavage of SNAP-25. It follows that SNAP-23 reconstitution is not due to competitive inhibition of toxin cleavage of SNAP-25 but, rather, to the ability of SNAP-23 to replace the toxininactivated endogenous SNAP-25.
SNAP-23 was strongly overexpressed in the transfected cells in which regulated secretion was reconstituted. In a separate series of experiments, it was observed that with lower levels of SNAP-23 expression (albeit still elevated relative to the endogenous level) reconstitution was less efficient (data not shown). This observation could be explained by the fact that SNAP-25 can still be engaged in a complex with syntaxin and VAMP even after cleavage by BoNT/E (42). It could therefore compete with exogenous SNAP-23 for binding to the other SNAREs. Alternatively, our results may indicate that SNAP-23, while being able to replace SNAP-25 in the process of regulated hormone secretion, is probably less effective in this process. Each isoform may thus have its own specific (SNARE) binding partners and a discrete, albeit mechanistically similar, functional role within the cell. To ensure a high degree of specificity, with segregation of pathways in the face of similar molecular mechanisms, it is to be expected that the affinity of SNAP-23 for the natural binding partners of SNAP-25 (and presumably the contrary as well) would be low.
Inhibition of neurotransmitter release by BoNT/E has been generally accepted to be due to cleavage of SNAP-25. An important role has therefore been attributed to SNAP-25 in the process of regulated exocytosis. To date, however, no direct proof had been obtained to ensure that SNAP-25 is the only target of BoNT/E important in regulated exocytosis. As a metallo-endoprotease, BoNT/E may hydrolyze additional proteins so far not detected with commonly used antibodies to known proteins. BoNT/C for instance, previously thought to hydrolyze only syntaxin, has recently been shown to cleave also SNAP-25 (16, 43, 44) . The results of the present study show, however, that secretion from toxin-treated cells can be completely reconstituted by overexpression of SNAP-23. We therefore conclude that SNAP-25 (or a close homologue) is the only BoNT/E-sensitive protein important in the process of regulated exocytosis. 
